LEADER 00880nam0-22002891i-450-
001 990003866990403321
005 20070111132807.0
035   $a000386699
035   $aFED01000386699
035   $a(Aleph)000386699FED01
035   $a000386699
100   $a20030910d2000----km-y0itay50------ba
101 0 $aeng
102   $aIT
200 1 $aAdoption of an IMF programme and debt rescheduling$ean empirical analysis$fSilvia Marchesi
210   $aPisa$cUniversità degli studi di Pisa$d2000
215   $a35 p.$d30 cm
225 1 $aStudi e ricerche$v2000.65
320   $aRiferimenti bibliografici: p. 31-32
700  1$aMarchesi,$bSilvia$080751
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990003866990403321
952   $aPaper 47/2000.65$fSES
959   $aSES
996   $aAdoption of an IMF programme and debt rescheduling$9513981
997   $aUNINA

LEADER 02000nam  2200601 a 450 
001 9910455766903321
005 20200520144314.0
010   $a1-280-19145-7
010   $a9786610191451
010   $a0-309-53857-2
010   $a0-585-14922-4
035   $a(CKB)110986584752060
035   $a(OCoLC)43477138
035   $a(CaPaEBR)ebrary10060408
035   $a(SSID)ssj0000266425
035   $a(PQKBManifestationID)11200825
035   $a(PQKBTitleCode)TC0000266425
035   $a(PQKBWorkID)10304035
035   $a(PQKB)11785491
035   $a(MiAaPQ)EBC3376839
035   $a(Au-PeEL)EBL3376839
035   $a(CaPaEBR)ebr10060408
035   $a(OCoLC)814270801
035   $a(EXLCZ)99110986584752060
100   $a19970822d1997      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aVaccine safety forum$b[electronic resource] $esummaries of two workshops /$fVaccine Safety Forum, Board on Health Promotion and Disease Prevention, Institute of Medicine
210   $aWashington, D.C. $cNational Academy Press$d1997
215   $a1 online resource (71 p.) 
225 1 $aThe compass series
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a0-309-05791-4 
320   $aIncludes bibliographical references.
410  0$aCompass series (Washington, D.C.)
606   $aVaccination$xComplications$zUnited States$xPrevention
606   $aVaccination of children$xComplications$zUnited States$xPrevention
606   $aVaccines$zUnited States$xSafety measures
608   $aElectronic books.
615  0$aVaccination$xComplications$xPrevention.
615  0$aVaccination of children$xComplications$xPrevention.
615  0$aVaccines$xSafety measures.
676   $a615/.372
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910455766903321
996   $aVaccine safety forum$92180322
997   $aUNINA